NSAID: Current limits to prescription

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

Scott D. Solomon, John J.V. McMurray, Marc A. Pfeffer et al. · New England Journal of Medicine · 2005 · 2.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely et al. · Annals of the Rheumatic Diseases · 2020 · 1.2K citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

Celecoxib versus Diclofenac and Omeprazole in Reducing the Risk of Recurrent Ulcer Bleeding in Patients with Arthritis

Francis K.L. Chan, Lawrence C.T. Hung, Bing Yee Suen et al. · New England Journal of Medicine · 2002 · 559 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial

Francis K.L. Chan, Vincent Wai Sun Wong, Bing Yee Suen et al. · The Lancet · 2007 · 339 citations

Medicine, Pharmacology, Pharmacotherapy +15

Individual NSAIDs and Upper Gastrointestinal Complications

Jordi Castellsagué, Nuria Riera‐Guàrdia, Brian Calingaert et al. · Drug Safety · 2012 · 331 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14